IM Cannabis (IMCC) Invested Capital (2020 - 2026)

IM Cannabis has reported Invested Capital for 7 years, with the latest figure at $4.7 million in Q2 2026.

• On a quarterly basis, Invested Capital fell 66.52% year-over-year to $4.7 million in Q2 2026; TTM through Jun 2026 was $4.7 million, a 66.52% decrease from a year earlier, with the FY2025 full-year figure at $8.8 million, down 41.96% from the prior year.
• Invested Capital was $4.7 million for Q2 2026 at IM Cannabis, up from -$3.3 million in the prior quarter.
• The five-year high for Invested Capital was $169.2 million in Q1 2022, with the low at -$3.3 million in Q1 2026.
• Average Invested Capital over 5 years is $31.9 million, with a median of $15.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Invested Capital soared 31.53% in 2022, then slumped 189.81% in 2026.
• Over 5 years, Invested Capital stood at $24.6 million in 2022, then retreated by 21.85% to $19.3 million in 2023, then slipped by 22.95% to $14.8 million in 2024, then sank by 40.66% to $8.8 million in 2025, then plunged by 47.15% to $4.7 million in 2026.
• The last three Invested Capital figures came in at $4.7 million (Q2 2026), -$3.3 million (Q1 2026), and $8.8 million (Q4 2025), per Business Quant data.